Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFRmutation

Peer Review reports

Original Submission
17 Jan 2013	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
25 Feb 2013	Reviewed	Reviewer Report - Ben Markman
15 Mar 2013	Reviewed	Reviewer Report - Christopher Lewis
22 Apr 2013	Author responded	Author comments - Akihiko Miyanaga
Resubmission - Version 3
22 Apr 2013	Submitted	Manuscript version 3
23 Apr 2013	Reviewed	Reviewer Report - Christopher Lewis
6 May 2013	Reviewed	Reviewer Report - Ben Markman
15 May 2013	Author responded	Author comments - Akihiko Miyanaga
Resubmission - Version 4
15 May 2013	Submitted	Manuscript version 4
Publishing
22 May 2013	Editorially accepted
29 May 2013	Article published	10.1186/1471-2407-13-262

Back to article page